China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

SHA:600062 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,024	2,851	3,462	2,630	2,834	2,410
Trading Asset Securities	502.02	-	-	200.49	803.58	851.95
Cash & Short-Term Investments	2,526	2,851	3,462	2,831	3,638	3,262
Cash Growth	11.06%	-17.65%	22.29%	-22.18%	11.51%	20.73%
Accounts Receivable	3,059	2,599	2,633	2,211	1,978	2,086
Other Receivables	106.38	209.04	1,363	468.98	66.14	50.5
Receivables	3,165	2,808	3,997	2,680	2,044	2,137
Inventory	1,624	1,594	1,688	1,900	1,665	1,289
Prepaid Expenses	-	-	-	-	0.59	-
Other Current Assets	257.91	224.59	235.49	227.89	174.55	112.22
Total Current Assets	7,573	7,477	9,382	7,639	7,523	6,800
Property, Plant & Equipment	4,221	4,238	4,046	3,571	2,957	2,673
Long-Term Investments	1,068	1,048	1,016	350.29	303.43	370.08
Goodwill	878.49	878.49	907.9	934.96	788.19	796.41
Other Intangible Assets	1,726	1,749	1,768	1,648	1,193	1,094
Long-Term Accounts Receivable	1.96	2.37	-	-	-	-
Long-Term Deferred Tax Assets	108.93	135.8	140.58	127.19	73.77	52.22
Long-Term Deferred Charges	647.47	744.92	813	792.3	723.66	569.38
Other Long-Term Assets	515.39	412.4	129.8	103.27	114.6	60.72
Total Assets	16,741	16,686	18,203	15,165	13,676	12,416
Accounts Payable	768.31	835.81	740.49	750.39	847.4	848.05
Accrued Expenses	1,756	2,296	1,691	1,496	1,283	1,149
Short-Term Debt	44.51	89.05	59.47	36.95	4.75	-
Current Portion of Long-Term Debt	12.12	12	200.25	0.27	-	-
Current Portion of Leases	5.25	11.31	22.49	19.46	17.84	-
Current Income Taxes Payable	53.23	43.84	65.72	77.78	59.62	58.92
Current Unearned Revenue	140.33	174.88	293.43	194.21	201.35	146.24
Other Current Liabilities	624.04	539.73	1,706	507.17	317.31	467.45
Total Current Liabilities	3,404	4,003	4,779	3,082	2,731	2,670
Long-Term Debt	1,099	1,090	-	200	-	-
Long-Term Leases	31.93	22.1	29.95	32.93	35.43	-
Long-Term Unearned Revenue	143.75	160.67	182.31	199.61	153.92	101.02
Long-Term Deferred Tax Liabilities	112.03	123.6	158.59	176.17	120.35	103.62
Other Long-Term Liabilities	5.67	5.67	5.67	5.06	1.11	14.4
Total Liabilities	4,965	5,574	5,303	3,840	3,199	3,040
Common Stock	1,039	1,039	1,040	1,043	1,043	1,043
Additional Paid-In Capital	200.34	193.45	837.55	275.22	149.39	149.39
Retained Earnings	9,859	9,269	10,460	9,415	8,718	8,102
Treasury Stock	-40.86	-74.36	-125.56	-175.68	-	-
Comprehensive Income & Other	-16.59	-19.3	1.32	-1.43	-5.17	-0.28
Total Common Equity	11,041	10,408	12,213	10,556	9,905	9,294
Minority Interest	735.44	703.89	685.95	768.46	571.06	82.88
Shareholders' Equity	11,776	11,112	12,899	11,325	10,477	9,377
Total Liabilities & Equity	16,741	16,686	18,203	15,165	13,676	12,416
Total Debt	1,193	1,224	312.16	289.61	58.02	-
Net Cash (Debt)	1,333	1,626	3,150	2,541	3,580	3,262
Net Cash Growth	-33.97%	-48.36%	23.94%	-29.00%	9.73%	23.67%
Net Cash Per Share	1.30	1.58	3.07	2.45	3.43	3.13
Filing Date Shares Outstanding	1,033	1,027	1,021	1,040	1,043	1,043
Total Common Shares Outstanding	1,033	1,027	1,021	1,040	1,043	1,043
Working Capital	4,170	3,474	4,602	4,556	4,792	4,130
Book Value Per Share	10.69	10.13	11.96	10.15	9.49	8.91
Tangible Book Value	8,437	7,780	9,537	7,973	7,925	7,403
Tangible Book Value Per Share	8.17	7.57	9.34	7.67	7.60	7.10
Buildings	3,479	3,452	3,162	2,579	2,314	2,171
Machinery	4,433	4,358	4,000	3,306	2,758	2,578
Construction In Progress	479.65	455.14	570.38	439.72	272.81	281.03

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.